% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 30

Loading Chart...

16 inventors (with patents filed for the assignee):

Paul B Robbins (4 out of 5 patents)

Longwu Qi (3 out of 4 patents)

Raj Gopal Venkat (3 out of 3 patents)

4. Sudhir R Sahasrabudhe (3 out of 3 patents)

5. Robert Selliah (3 out of 4 patents)

6. Brent R Stockwell (2 out of 25 patents)

7. Moritz Von Rechenberg (2 out of 11 patents)

8. John M Peltier (2 out of 2 patents)

9. John Jay Boniface (1 out of 6 patents)

10. Michael Pierce (1 out of 2 patents)

11. Robert R Becklin (1 out of 1 patent)

12. Cindy Lou Chepanoske (1 out of 1 patent)

13. Keith Simmon (1 out of 1 patent)

14. Eugene Y Zhen (1 out of 1 patent)

15. Vladimir Kery (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 8575143 - 3-aryl-substituted quinazolones, and uses thereof (2013-11-05),

2. 8518959 - Quinoxaline derivatives as antitumor agents (2013-08-27),

3. 7825227 - Method for purification of a protein complex and identification of its components (2010-11-02),

4. 7615554 - Erastin and erastin binding proteins, and uses thereof (2009-11-10),

Prolexys Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative therapies for cancer and other diseases. With a team of experienced scientists and cutting-edge technology, Prolexys is dedicated to advancing the field of drug discovery. The company's research efforts are centered around identifying novel drug targets and developing targeted therapies that have the potential to improve patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

4 Patents

#287 in Salt Lake City, UT

#777 in Utah

#60,561 in US

Salt Lake City, UT, United States of America

Prolexys Pharmaceuticals, Inc.